The second aim of the study was to assess the cell-surface expression of CCR1 and CCR2 in PB lymphocytes of RA and OA patients in comparison with the healthy individuals and correlate the CCR1/CCR2-positivity with the disease. The gene discussed is CCR1; the disease is rheumatoid arthritis.